Lyell Immunopharma, Inc.
LYEL
DELAYED 1 MONTH
6 insider filings · Latest: Jul 27, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 11 8:07 PM | David ShookChief Medical Officer | Sale | 1,977 | $12.64 | $25.0K | 20,923(D) | View → |
| Mar 6, 2026 | Mar 9 8:36 PM | ARCH Venture Partners IX, LLC10% Owner | Purchase | 488,090 | $25.61 | $12.5M | 1,426,528(I) | View → |
| Mar 6, 2026 | Mar 9 8:34 PM | ARCH Venture Fund XIII, L.P.10% Owner | Purchase | 488,090 | $25.61 | $12.5M | 1,426,528(I) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 16 11:26 PM | Smital ShahChief Fin. and Bus. Officer | Grant/Award | 140,000 | $25.50 | 140,000(D) | View → |